MOXIE DWIGHT (SVP, GC & Secretary) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2025ACC: 0000950170-25-015361
Officer· SVP, GC & Secretary
Since Feb 2020
-143.79K
Net shares
Net seller
$174.5K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
18.13K acquired · 161.92K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−47.81K
Price / share
$3.65
Trade value
$174.52K
% of position
33.3%
2/4/2025
143.79K→95.98K
Common Stock
Direct
Shares
−95.98K
Price / share
—
Trade value
—
% of position
New position
2/6/2025
95.98K→0.00
Common Stock
Direct
Shares
+18.13K
Price / share
—
Trade value
—
% of position
New position
2/6/2025
0.00→18.13K
Common Stock
Direct
Shares
−18.13K
Price / share
—
Trade value
—
% of position
New position
2/6/2025
18.13K→0.00
Total
Net shares
−143.79K
Net value
-$174.52K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/4/2025 | U · U | −47.81K | $3.65 | $174.52K | 33.3% | 143.79K | 95.98K |
| Common Stock Direct | 2/6/2025 | D · Disposition | −95.98K | — | — | New position | 95.98K | 0.00 |
| Common Stock Direct | 2/6/2025 | A · Award | +18.13K | — | — | New position | 0.00 | 18.13K |
| Common Stock Direct | 2/6/2025 | D · Disposition | −18.13K | — | — | New position | 18.13K | 0.00 |
| Total | −143.79K | -$174.52K | ||||||
Derivative Transactions0
No derivative transactions reported